Talzenna (talazoparib)

**Product type:** Human Prescription Drug

**Active ingredient:** TALAZOPARIB TOSYLATE

**Strength:** .5 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** U.S. Pharmaceuticals

**Marketing category:** NDA (NDA211651)

**Pharmacologic class:** Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]